MedPath

Peking University First Hospital (Peking Univesity First Medical School)

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Effect of Oliceridine Analgesia on Postoperative Nause and Vomiting

Phase 4
Recruiting
Conditions
Postoperative Nausea and Vomiting
Interventions
First Posted Date
2024-05-13
Last Posted Date
2024-10-08
Lead Sponsor
Peking University First Hospital
Target Recruit Count
252
Registration Number
NCT06411665
Locations
🇨🇳

Dong-Xin Wang, Beijing, China

Effect of Dexmedetomidine and Esketamine on Catheter-related Bladder Discomfort

Phase 4
Recruiting
Conditions
Urinary Catheter
Catheter-related Bladder Discomfort
Dexmedetomidine
Esketamine
Interventions
Drug: Normal saline
Drug: Combined dexmedetomidine-esketamine
First Posted Date
2024-05-03
Last Posted Date
2024-06-07
Lead Sponsor
Peking University First Hospital
Target Recruit Count
1740
Registration Number
NCT06399185
Locations
🇨🇳

Peking University Shenzhen Hospital, Shenzhen, Guangdong, China

🇨🇳

Peking University First Hospital, Beijing, Beijing, China

The Effect of OSA on Severity and Prognosis of Patients With IgAN

Not yet recruiting
Conditions
Obstructive Sleep Apnea
IgA Nephropathy
Interventions
Device: Continuous Positive Airway Pressure
First Posted Date
2024-05-01
Last Posted Date
2024-06-04
Lead Sponsor
Peking University First Hospital
Target Recruit Count
200
Registration Number
NCT06393036

The Effect of OSA on Severity and Prognosis of Patients With CKD

Not yet recruiting
Conditions
Obstructive Sleep Apnea
Chronic Kidney Diseases
First Posted Date
2024-05-01
Last Posted Date
2024-06-04
Lead Sponsor
Peking University First Hospital
Target Recruit Count
200
Registration Number
NCT06393023

Comparison of MRI Artificial Intelligence-guided cTB Versus Routine cTB in Prostate Cancer Diagnosis

Not Applicable
Recruiting
Conditions
Prostate Cancer
Interventions
Procedure: Routine cognitive prostate targeted biopsy
Procedure: MRI-AI guided cognitive prostate targeted biopsy
First Posted Date
2024-04-30
Last Posted Date
2024-05-06
Lead Sponsor
Peking University First Hospital
Target Recruit Count
360
Registration Number
NCT06392737
Locations
🇨🇳

Peking University First Hospital, Beijing, Beijing, China

Establishment of a Multidimensional Prediction Model for the Natural Course of VHL Disease-related Renal Cell Carcinoma

Recruiting
Conditions
Renal Cell Carcinoma
VHL Syndrome
Interventions
Genetic: Single cell sequencing, whole genome and metabolomic sequencing
First Posted Date
2024-04-30
Last Posted Date
2024-04-30
Lead Sponsor
Peking University First Hospital
Target Recruit Count
300
Registration Number
NCT06391879
Locations
🇨🇳

Peking University First Hospital, Beijing, Beijing, China

The Effect of OSA on Pregnancy and Fetal Outcomes

Not yet recruiting
Conditions
Pregnancy
Obstructive Sleep Apnea
First Posted Date
2024-04-30
Last Posted Date
2024-06-04
Lead Sponsor
Peking University First Hospital
Target Recruit Count
500
Registration Number
NCT06391138

Effect of OSA Resulting From Chronic Tonsillitis on Pregnancy Outcomes

Not yet recruiting
Conditions
Pregnancy
Chronic Tonsillitis
Obstructive Sleep Apnea
First Posted Date
2024-04-30
Last Posted Date
2024-06-04
Lead Sponsor
Peking University First Hospital
Target Recruit Count
500
Registration Number
NCT06391151

Exploration of the Value of PSMA PET/CT in Dynamic Monitoring of the Efficacy of Novel Endocrine Therapy in Patients With Metastatic Hormone Sensitive Prostate Cancer

Not Applicable
Not yet recruiting
Conditions
Prostate Adenocarcinoma
Interventions
Diagnostic Test: PSMA PET/CT
First Posted Date
2024-04-29
Last Posted Date
2024-04-29
Lead Sponsor
Peking University First Hospital
Target Recruit Count
150
Registration Number
NCT06387238

PET Imaging Study of 68Ga-NB381 in Multiple Myeloma

Early Phase 1
Recruiting
Conditions
Multiple Myeloma
Interventions
First Posted Date
2024-04-26
Last Posted Date
2024-04-26
Lead Sponsor
Peking University First Hospital
Target Recruit Count
30
Registration Number
NCT06385652
Locations
🇨🇳

Peking University First Hospital, Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath